Small Cap Growth Fund
Name
As of 12/20/2024Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
Vitals
YTD Return
11.9%
1 yr return
12.8%
3 Yr Avg Return
-4.3%
5 Yr Avg Return
2.8%
Net Assets
$427 M
Holdings in Top 10
15.3%
52 WEEK LOW AND HIGH
Expenses
OPERATING FEES
Expense Ratio 0.92%
SALES FEES
Front Load N/A
Deferred Load N/A
TRADING FEES
Turnover 40.00%
Redemption Fee N/A
Min Investment
Standard (Taxable)
$0
IRA
N/A
Fund Classification
Fund Type
Open End Mutual Fund
Name
As of 12/20/2024Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
VVSGX - Profile
Distributions
- YTD Total Return 11.9%
- 3 Yr Annualized Total Return -4.3%
- 5 Yr Annualized Total Return 2.8%
- Capital Gain Distribution Frequency Annually
- Net Income Ratio -0.84%
- Dividend Yield 0.0%
- Dividend Distribution Frequency Annual
Fund Details
-
Legal NameSmall Cap Growth Fund
-
Fund Family NameVALIC Company
-
Inception DateSep 01, 2006
-
Shares OutstandingN/A
-
Share ClassOther
-
CurrencyUSD
-
Domiciled CountryUS
-
ManagerEytan Shapiro
Fund Description
VVSGX - Performance
Return Ranking - Trailing
Period | VVSGX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | 11.9% | -2.9% | 66.6% | 72.96% |
1 Yr | 12.8% | -0.8% | 63.5% | 60.19% |
3 Yr | -4.3%* | -14.5% | 60.5% | 77.30% |
5 Yr | 2.8%* | -4.4% | 45.2% | 96.48% |
10 Yr | 2.5%* | 1.2% | 24.6% | 99.74% |
* Annualized
Return Ranking - Calendar
Period | VVSGX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | 5.6% | -20.5% | 54.6% | 94.98% |
2022 | -37.7% | -82.1% | 32.2% | 82.36% |
2021 | -15.6% | -90.6% | 300.1% | 73.21% |
2020 | 40.0% | -63.0% | 127.9% | 25.64% |
2019 | 5.5% | -7.7% | 42.9% | 97.59% |
Total Return Ranking - Trailing
Period | VVSGX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | 11.9% | -2.9% | 66.6% | 72.96% |
1 Yr | 12.8% | -0.8% | 63.5% | 60.19% |
3 Yr | -4.3%* | -14.5% | 60.5% | 77.30% |
5 Yr | 2.8%* | -4.4% | 45.2% | 96.48% |
10 Yr | 2.5%* | 1.2% | 24.6% | 99.74% |
* Annualized
Total Return Ranking - Calendar
Period | VVSGX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | 14.3% | -19.0% | 136.8% | 64.13% |
2022 | -32.4% | -59.9% | 44.3% | 78.05% |
2021 | -5.0% | -22.7% | 411.9% | 94.34% |
2020 | 40.0% | 1.5% | 150.8% | 44.42% |
2019 | 5.5% | 5.5% | 55.3% | 100.00% |
NAV & Total Return History
VVSGX - Holdings
Concentration Analysis
VVSGX | Category Low | Category High | VVSGX % Rank | |
---|---|---|---|---|
Net Assets | 427 M | 209 K | 34.3 B | 61.11% |
Number of Holdings | 155 | 7 | 1226 | 23.15% |
Net Assets in Top 10 | 84.8 M | 53.8 K | 3.02 B | 66.30% |
Weighting of Top 10 | 15.25% | 7.5% | 100.0% | 84.42% |
Top 10 Holdings
- Halozyme Therapeutics Inc 1.85%
- Applied Industrial Technologies Inc 1.75%
- FTAI Aviation Ltd 1.69%
- Casella Waste Systems Inc 1.60%
- Cactus Inc 1.47%
- Evolent Health Inc 1.45%
- Insmed Inc 1.41%
- AAON Inc 1.39%
- Verra Mobility Corp 1.33%
- Vaxcyte Inc 1.31%
Asset Allocation
Weighting | Return Low | Return High | VVSGX % Rank | |
---|---|---|---|---|
Stocks | 98.89% | 92.05% | 107.62% | 31.30% |
Cash | 1.05% | 0.00% | 28.78% | 66.67% |
Preferred Stocks | 0.16% | 0.00% | 4.59% | 12.59% |
Other | 0.00% | -0.26% | 6.70% | 33.52% |
Convertible Bonds | 0.00% | 0.00% | 1.57% | 87.22% |
Bonds | 0.00% | 0.00% | 2.40% | 87.59% |
Stock Sector Breakdown
Weighting | Return Low | Return High | VVSGX % Rank | |
---|---|---|---|---|
Healthcare | 25.71% | 0.00% | 47.90% | 23.89% |
Technology | 25.54% | 2.91% | 75.51% | 48.33% |
Industrials | 18.10% | 0.00% | 36.64% | 38.89% |
Consumer Cyclical | 15.14% | 0.00% | 24.04% | 22.59% |
Consumer Defense | 5.98% | 0.00% | 13.56% | 18.15% |
Financial Services | 3.99% | 0.00% | 42.95% | 82.78% |
Energy | 2.42% | 0.00% | 55.49% | 55.00% |
Real Estate | 2.22% | 0.00% | 15.31% | 48.70% |
Communication Services | 0.62% | 0.00% | 15.31% | 77.41% |
Utilities | 0.24% | 0.00% | 5.57% | 30.93% |
Basic Materials | 0.03% | 0.00% | 9.24% | 84.81% |
Stock Geographic Breakdown
Weighting | Return Low | Return High | VVSGX % Rank | |
---|---|---|---|---|
US | 98.89% | 17.30% | 107.62% | 26.85% |
Non US | 0.00% | 0.00% | 77.12% | 90.93% |
VVSGX - Expenses
Operational Fees
VVSGX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Expense Ratio | 0.92% | 0.05% | 23.20% | 79.96% |
Management Fee | 0.81% | 0.05% | 1.62% | 57.33% |
12b-1 Fee | N/A | 0.00% | 1.00% | N/A |
Administrative Fee | 0.06% | 0.01% | 0.40% | 36.13% |
Sales Fees
VVSGX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Front Load | N/A | 3.50% | 5.75% | N/A |
Deferred Load | N/A | 1.00% | 5.00% | N/A |
Trading Fees
VVSGX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Max Redemption Fee | N/A | 1.00% | 2.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
VVSGX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Turnover | 40.00% | 3.00% | 264.00% | 37.21% |
VVSGX - Distributions
Dividend Yield Analysis
VVSGX | Category Low | Category High | VVSGX % Rank | |
---|---|---|---|---|
Dividend Yield | 0.00% | 0.00% | 6.91% | 90.19% |
Dividend Distribution Analysis
VVSGX | Category Low | Category High | Category Mod | |
---|---|---|---|---|
Dividend Distribution Frequency | Annual | Annual | SemiAnnual | Annual |
Net Income Ratio Analysis
VVSGX | Category Low | Category High | VVSGX % Rank | |
---|---|---|---|---|
Net Income Ratio | -0.84% | -2.47% | 1.10% | 61.42% |
Capital Gain Distribution Analysis
VVSGX | Category Low | Category High | Capital Mode | |
---|---|---|---|---|
Capital Gain Distribution Frequency | Annually | Annually | Semi-Annually | Annually |
Distributions History
Date | Amount | Type |
---|---|---|
Mar 07, 2023 | $0.001 | CapitalGainShortTerm |
Mar 07, 2023 | $1.133 | CapitalGainLongTerm |
Mar 09, 2022 | $0.445 | CapitalGainShortTerm |
Mar 09, 2022 | $0.980 | CapitalGainLongTerm |
May 13, 2021 | $0.000 | OrdinaryDividend |
May 13, 2021 | $0.241 | CapitalGainShortTerm |
May 13, 2021 | $2.502 | CapitalGainLongTerm |
VVSGX - Fund Manager Analysis
Managers
Eytan Shapiro
Start Date
Tenure
Tenure Rank
Dec 31, 2007
14.42
14.4%
Eytan Shapiro, managing director, is the CIO of the Growth &Small Cap U.S. Equity Team. Mr. Shapiro has worked as a portfolio manager for JPMIM or its affiliates (or their predecessors) since 1989 and has been employed by the firm since 1985. Eytan holds a B.Sc. in economics from City University, London, an M.Phil. in economics from Oxford University, and is Series 66 licensed. He is a member of both the New York Society of Security Analysts and The CFA Institute, and a CFA charterholder. He began his investment career in 1982.
Matthew Cohen
Start Date
Tenure
Tenure Rank
Dec 22, 2016
5.44
5.4%
Matthew G. Cohen, M.D., managing director, is a research analyst in the U.S. Equity Group. An employee since 2005, Dr. Cohen has been portfolio manager since 2015 and a research analyst in the firm’s U.S. Equity Group since 2005. Before joining the firm, Matthew was a senior healthcare analyst at Medici Healthcare and a senior analyst covering medical products at Narragansett Asset Management, a New York-based healthcare hedge fund. Prior to that, Dr. Cohen was a resident surgeon in the Department of General Surgery at the North Shore University Hospital NYU School of Medicine. Matthew holds an M.B.A. from New York University Stern School of Business and an M.D. from McGill University in Montreal.
Felise Agranoff
Start Date
Tenure
Tenure Rank
Dec 22, 2016
5.44
5.4%
Felise L. Agranoff, managing director, is a portfolio manager and research analyst within the U.S. Equity Group. An employee since 2004, Felise is a co-portfolio manager of the Mid Cap Growth, Growth Advantage and Small Cap Growth Strategies. Additionally, she has research responsibility for the small and mid cap industrial sector as well as mid cap financials and business services. Prior to joining the growth team as a research analyst in 2006, Felise previously worked on the J.P. Morgan U.S. Equity Large Cap fundamental research team. Felise obtained a B.S. in Finance and Accounting from the McIntire School of Commerce at the University of Virginia. She is a member of the CFA Institute and a CFA charterholder.
Frank Alonso
Start Date
Tenure
Tenure Rank
May 25, 2021
1.02
1.0%
Francisco (Frank) M. Alonso joined T. Rowe Price Associates in 2000 and is currently a Vice President of T. Rowe Price Group and T. Rowe Price Associates. He is also the portfolio manager for the Small-Cap Stock Fund. From 2013 to September 2016 Frank ran the US Smaller Companies Equity Fund (SICAVS) and was the Associate PM for the Small-Cap Stock Fund. Prior to 2013 he worked as an investment analyst in TRP’s U.S. Equity Division covering discount stores, soft goods retailing and hard goods under the consumer industry.
Tenure Analysis
Category Low | Category High | Category Average | Category Mode |
---|---|---|---|
0.08 | 30.44 | 9.17 | 5.25 |